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1.0 Introduction
1.1 Circadian Rhythms and the
Suprachiasmatic Nucleus
Circadian
clocks
regulate
physiological processes in nearly all
organisms.
Located
within
the
hypothalamus, the mammalian central
clock identified as the suprachiasmatic
nucleus (SCN) synchronizes peripheral
clocks. Lesioning the SCN eliminates
circadian rhythm patterns associated
with body temperature, sleep, locomotor
activity and hormones [1-3]. Retinal
ganglion cells signal the presence of light
to the SCN via the retinohypothalamic
tract (RHT) and release of the
neurotransmitter,
glutamate.
The
intracellular processes associated with
glutamate signaling (outlined below) are
well
understood;
however,
the
extracellular processes involved with
light-induced glutamate signaling are not
completely understood.
The focus of my research is on a
group of extracellular proteins best
known for their role in the vasculature to
regulate
fibrinolysis:
tissue-type
plasminogen
activator
(tPA),
plasminogen, and plasminogen activator
inhibitor-1 (PAI-1). Experiments have
determined that these proteins also
function in SCN to modulate photic
regulation of the circadian clock. Brainderived neurotrophic factor (BDNF) is
required for light/glutamate to reset the
clock; it is activated by plasmin which is
produced from plasminogen by tPA [4].
Glutamate-induced phase shifts are
blocked by PAI-1, which stays active
through binding with vitronectin, (VN)
[4]. However, the precise spatial and

temporal characteristics of these proteins’
activities and interactions have yet to be
determined. Our goal is to answer
questions about the mechanisms through
which these proteins regulate glutamate
signaling in the SCN. This includes spatial
location of tPA and PAI-1 in the SCN and
how they change over the circadian cycle.

1.2 Importance of Fibrinolytic
Proteins in Clinical Areas
The roles of tPA, PAI-1 and
plasminogen in fibrinolysis are well
known. Fibrinolysis, the body’s ability to
degrade fibrin, is an integrated part of
hemostasis. Overactivity causes bleeding
and underactivity causes thrombosis.
Abnormal structural variants and
abnormal levels of tPA, PAI-1 and
plasminogen give rise to bleeding or to
thrombosis [5]. The biological control of
tPA-mediated fibrinolysis is both cellular
and humoral, indicating its physiological
importance [6]. The cellular regulation
involves synthesis of tPA and PAI-1 as
well as their release/uptake. The humoral
regulation includes the tPA/PAI-1
reaction,
the
fibrin-stimulated
plasminogen activation and the plasmin
degradation of fibrin [6]. More recently
these proteins have been shown to affect
normal brain functions, including neural
remodeling in early development, stressinduced anxiety in the amygdala, and
learning behaviors [7-10]. tPA’s activity in
the brain is most prominent in the
hippocampus and the hypothalamus[11].
However, less is known about the roles
these extracellular proteases play in the
SCN.
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1.3
Tissue-type
Plasminogen
Activator (tPA) & Plasmin
Tissue-type plasminogen activator
(tPA) is an extracellular protease that
cleaves plasminogen into the active form
plasmin. This is a crucial step in the
cascade of events shown in Figure 1. In
the vasculature this helps regulate
fibrinolysis, while in the brain it appears
to regulate NMDA/glutamate signaling
(12, 13). There is accumulating evidence
that tPA/plasmin are involved in SCN
physiology.
The SCN is anatomically and
functionally
organized
into
two
subdivisions: a core that lies adjacent to
the optic chiasm and a shell that
surrounds the core in its dorsomedial
portion [14]. Plasminogen expression is
prominent in the dorsomedial shell
portion of the SCN [14]. tPA has been
shown to localize at vasopressincontaining neurons within the SCN, where
high levels of plasminogen have been
found [15, 16]. Due to the actions of tPA
on plasminogen, it is expected to be
located in the same region of the brain as
plasminogen. tPA is often found in
extracellular milieu, as a soluble protein,
or bound to extracellular matrix (ECM) or
cell-surface
receptors; its
activity
depends on its location and partners with
which it interacts. For example, tPA can
bind to the ECM proteins fibrin [17, 18]
and laminin [19, 20] or to annexin II [2123] and α-enolase [23, 24]located on cell
membranes. tPA is inhibited directly or
indirectly by several proteins but we will
focus on its inhibition by plasminogen
activator inhibitor (PAI-1); PAI-1 stability
is enhanced when it is bound to
vitronection (VN) as described in Section
1.4. It has been determined that tPA
mRNA levels are expressed rhythmically
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in the adult SCN, with a peak in late day
[25].
As mentioned, the product of tPA
cleavage of plasminogen is plasmin.
Plasmin has well documented roles in
fibrinolysis [26], wound healing [27], and
ECM
degradation
[27].
In
the
hippocampus, plasmin converts the
inactive pro-BDNF to the active form,
mBDNF, which is necessary to enhance
the cellular processes associated with
long term potentiation (LTP), which
underlies learning [20]. Our research
suggests that tPA and plasmin function in
a similar manner in the SCN. α2antiplasmin (an endogenous inhibitor of
plasmin) inhibits glutamate-induced
phase shifts and decreases the conversion
of inactive to active BDNF in the SCN [4].
Exogenous mBDNF (200 ng/mL) applied
30 minutes prior to co-application of
glutamate and α2-antiplasmin fully
restores the glutamate-induced phase
shifts [4]. This phase shift cannot be
accomplished without the presence of
glutamate; mBDNF on its own has no
effect on the phase shift [4]. These data
support the model shown in Figure 1; our
working model is that plasmin cleaves the
inactive form of BDNF, pro-BDNF, into the
active form, m-BDNF. m-BDNF activates
the TrkB receptor, which in turn
enhances NMDA channel activity. This
ultimately allows glutamate to induce
clock phase shifts.

1.4
Plasminogen
Activator
Inhibitor-1 (PAI-1) & Vitronectin
PAI-1 is a protease that acts
primarily to inhibit tPA activity. PAI-1
binds to a glycoprotein called vitronectin
(VN); this interaction increases PAI-1’s
stability 10-fold. Similar to tPA, PAI-1
mRNA levels are expressed rhythmically
4
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in the adult SCN. PAI-1 mRNA levels peak
approximately 6 hours after peak levels of
tPA mRNA [28]; PAI-1 mRNA levels are
modulated by BDNF [29]. In previous
studies, PAI-1 effects in the SCN were well
documented. Glutamate (1mM) applied to
brain slices in the early subjective night
for 10 minutes delayed the SCN neuronal
activity rhythm by 2-3 hours [4].
Pretreating the brain slices with PAI-1 for
30 minutes prior to glutamate application
blocked these glutamate-induced phaseshifts from occurring [4]. This inhibition
is dependent on PAI-1 dosage and can be
overcome by excess tPA application [4].
VN (62 kD glycoprotein) stabilizes
PAI-1 by opposing PAI-1’s tendency to
relax to an inactive form [30-33]. It is
necessary for PAI-1 actions in the SCN[4].
Experiments have shown that PAI-1 is not
capable of blocking glutamate-induced
phase shifts in brain slices prepared from
VN knockout mice; PAI-1 could not inhibit
these phase shifts without its cofactor, VN
[4]. VN stabilizes PAI-1 via extensive
interactions and also localizes PAI-1 to
specific extracellular locations. Notably,
VN is expressed in neural tissues during
development and following trauma [3440]. Microarray studies have found that
VN mRNA is expressed in the SCN but is
not rhythmic [41].
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these proteins. This is an immortalized
cell line derived from rat SCN. Its
distinguishing characteristic is the ability
to generate circadian rhythms similar to
those of the SCN in vivo [42]. Thus, these
cells are not only capable of measuring
time (like a clock) but also of regulating
the timing of other events (as a
pacemaker). Their pace-making ability
has been determined in vivo. The
behavioral activity of intact rats is highest
at night, while SCN-lesioned rats exhibit
arrhythmicity. After transplantation of
SCN2.2 cells into the hypothalamus, the
circadian rhythm of wheel-running
behavior was restored within 4-10 days
[42].
tPA

INHIBITS

PAI-1
VN

Plasmin
Plasminogen

Pro-BDNF
(inactive)

m-BDNF
(active)
Interacts
with
receptor

Glutamate
Flows in

NMDA Glutamate
TrkB
Channel
Receptor
Opens

1.5 Proposal & Hypothesis
We believe that the fibrinolytic
proteins described above affect the
circadian clock in part through their
ability to activate BDNF. If this is the case,
then these proteins should be localized
extracellularly, possibly associated with
the extracellular matrix. Our goal is to
assess the spatial location of the above
mentioned proteins and how they change
over the circadian cycle. SCN2.2 cells are a
good model system in which to study

CLOCK SHIFT!
Figure 1. The extracellular protease, tPA, cleaves
plasminogen into plasmin. Plasmin turns the inactive form
of BDNF, pro-BDNF, into the active form, m-BDNF. m-BDNF
interacts with the TrkB Receptor on the cell membrane,
opening up the glutamate NMDA channels. Glutamate now
freely flows in the cell and causes a clock shift. As shown,
tPA activity is inhibited by the PAI-1/VN complex.
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2.0 Methods
2.1 Cell Culture Procedure
Frozen, immortalized SCN 2.2 cells
were thawed out and grown in laminincoated flasks at 37°C in Minimal Essential
Media (Gibco) supplemented with 10%
FBS (Fetal Bovine Serum), 2% glucose,
1% glutamine and 1% gentamicin until
>60% confluence. Before cells were
harvested, samples of media were
collected and stored at -80°C. Following
media collection, cells were rinsed with 6
ml of DPBS (Dulbecco PBS). Cells were
then lifted and lysed in 1 ml of 0.2M
ammonium hydroxide after a ten minute
incubation. Cell extracts were collected
and immediately stored at -80°C.
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fractions). Our protocol has been slightly
modified from the classical TCA
procedures in that we do not incubate our
proteins on ice or at -20°C for any amount
of time [43, 43].
The TCA/acetone
protein extraction procedure was chosen
to precipitate the proteins because it has
been proven to produce highly purified
tPA with a high yield [45]. After adding
ten percent volume of ice-cold 100% TCA
to each sample, samples were centrifuged
at 4°C for 30 minutes at 17,000 RPM, and
then the supernatant was discarded. 250
µl of ice-cold 1% TCA in acetone was
added to wash the pellet. Samples were
then vortexed, centrifuged at 4°C for 15
minutes at 17,000 RPM and the
supernatant was removed. After washing
twice with 1% TCA, the pellet was further
washed with 250 µl of ice-cold acetone,
centrifuged at 4°C for 5 minutes at 17,000
RPM and the supernatant was removed.
The samples were left to dry overnight.

For time-course samples, prior to
harvesting, cells were treated with
forskolin (FSK) dissolved in dimethyl
sulfoxide to synchronize the cells
(denoted as circadian time 0) or with
vehicle. Both FSK- or vehicle-treated
samples were collected at 3 hour
increments for up to 27 hours subsequent
to treatment.

The pellets were resuspended in
1X loading buffer containing sodium
dodecyl sulfate (SDS) and dithiothreitol,
followed by a series of boiling and mixing
steps. Each boiling step was 5 minutes
and at 100°C, and samples are stored in 20°C or immediately used for western
blotting.

2.2 Protein Extraction Procedure

2.3 Western Blots
SDS-Page and Immunoblotting

To assess protein expression, rat
SCN2.2 cells were isolated into three
fractions (media, ECM and cells) and then
frozen at -80°C for later Western blot
assay. These fractions were supplied by
former lab postdoctoral, Dr. Beth
Cantwell.
Trichloroacetic acid (TCA) was
used to precipitate proteins (from cell

TCA-extracted
samples
were
boiled for 5 minutes and loaded into 10%
SDS-polyacrylamide gels. Proteins in the
samples were separated by size and
transferred onto nitrocellulose by
electrophoresis in Tris-Glycine buffer.
Membranes were then rinsed with PBST
(1X phosphate buffered saline with 0.05%
Tween-20) and blocked in PBST with
6
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10% milk. Primary antibodies were
applied for 2 hours at room temperature
or overnight at -4°C,
4°C, rinsed, and
incubated with horseradish peroxidase
(HRP)-conjugated
conjugated secondary antibodies
for 1 hour. The
he primary antibody used
was
rabbit-anti-mouse
mouse
(Molecular
Innovations) in
n a concentration of 1:1000
with 2% milk and the secondary antibody
was horse-anti-mouse
mouse IgG (Vector
Laboratories) in a concentration of
1:2000 with 2% milk. Visualization was
performed using Supersignal West Pico
(Thermoscientific), a chemiluminescent
substrate cleaved by HRP.
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PAGE followed by western blotting with
antibodies for tPA as shown in Figure 2.
The tPA antibody gave immunoreactive
bands at approximately 62 kD,
corresponding to the expected weight.
wei
At
this point, our positive control (purified
PA protein) did not give a strong signal,
but we later confirmed the band
corresponded with the native protein. As
shown in Figure 2, the cell extract
replicates do not show up consistently.
However, the media
edia extracts have much
higher levels of protein.

Cell extracts and media prepared
by TCA extraction were subjected to SDS
SDS-

h band shown in Figures 2, 3, 4
Each
and 5 lies at approximately 62-kD,
62
which
matched
atched the positive control as shown in
Figure 3 and Figure 5 and is consistent
con
with
previous
studies
[4].

Vehicle-treated
treated
cell
extract
samples are shown alongside PAI
PAI-1 and
tPA positive controls in Figure 3. This
immunoblot shows weak expression of
tPA protein positive control.. The PAI-1
positive control shows cross-reactivity
reactivity to
the rabbit polyclonal, anti-mouse
mouse tPA
antibody. Later blots attempted to
address these re-occurring
occurring issues. In

many of our cell extract experiments,
including those in Figure 3, we attempted
to blot for actin,, which is a structural
protein
tein that should act to normalize the
amount of target protein in order to
control between groups. However, we
were not successful as no reactivity
appeared even in the extended (20
minutes)
exposures.

3.0 Results

7
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The vehicle treated cells act as a
control for the forskolin treated cells.
Forskolin activates adenylate cyclase [[46]
and is known to synchronize SCN cells in
vitro [47]. Figure 4 shows two w
western
blots of time-course
course samples that had

been collected from circadian time (CT) 3
to CT27. Figure 4A shows a vehiclevehicle
synchronized blot compared to Figure 4B
showing a forskolin-synchronized
synchronized blot. In
Figure 4B,, expression at CT6 and CT9
were
particularly
high.

While the cell extract samples
shown in Figure 5 below are not showing
a consistent amount of protein, the PAI
PAI-1
and tPA positive controls have a much

stronger presence even when loading a
small amount. This is due to using new
stock
ck
products.

8
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4.0 Discussion
The extracellular processes that
regulate glutamate signaling in the SCN
(and therefore its light-induced circadian
activity) are largely unknown. From our
previous study involving PAI-1/VN and
the tPA/plasmin proteolytic cascade, the
regulation of mBDNF production by these
proteins is a critical factor for the SCN
clock to respond to light/glutamate
signaling [4]. Prior studies have shown
that tPA is released into the extracellular
space, shifting the balance of proBDNF
secreted from dendrites to mature BDNF
[48]. Moreover, a recent report showed
that BDNF, tPA and plasmin protein are
packaged in dense core granules and
transported into dendrites [49].
In
the
SCN,
plasminogen
expression is prominent in the
dorsomedial shell [14]. Moreover, tPA
has been shown to localize at
vasopressin-containing neurons, where
high levels of plasminogen have been
found [15, 16]. However, these studies did
not address the critical issue of the
cellular localization of these proteins,
which we hypothesize to be located
extracellularly.
Our results suggest that tPA is
expressed in SCN neurons and,
importantly, it is present in the media.
Secretion of tPA into the media is
consistent with its proteolytic activities
shown in previous studies, although these
studies are not in the SCN. Therefore,
these results greatly strengthen our
hypothesis that these proteins act
extracellularly to regulate glutamateinduced phase shifts.
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In order to further confirm our
hypothesis, we need to determine
whether the tPA/plasmin and PAI-1
expression patterns in the media change
over 24 hours. Our data from FSKsynchronized cells appear to indicate
there are higher levels of tPA in the media
during mid-subjective day (CT3-9).
Unfortunately, these data are not
conclusive because the samples must be
normalized to actin to confirm equal
amounts of protein were loaded in each
lane. We are now focusing our work on
trouble-shooting the actin immunoblots.
Another concern is that the tPA
antibody reacted with the PAI-1 positive
controls. This cross-reactivity could be
due to a problem that occurred during the
antibody production. In addition, in
Figure 4, rather than having one specific
band in each blot, there were two
distinctive bands. In other blots, the
bands were not concise but rather
expansive. This could be due to the tPA
antibody binding non-specifically to other
proteins. Alternatively, tPA is known to be
cleaved into slightly smaller products, and
so these bands could represent those
cleavage products. In addition, different
isoforms of tPA have been reported, and
some of these are differentially
glycosylated [50, 51].
Until 2006, protein precipitation of
rat brain proteins had utilized the
TCA/acetone procedure [52]. Classical
TCA/acetone extraction methods have
been determined to be very effective as a
precipitant [53], instantly eliminating
proteolytic
and
other
modifying
enzymatic activity [54].
However, a
disadvantage of TCA precipitated protein
is that it is difficult to redissolve, and loss
of protein may occur [52, 55]. This may
explain the inconsistency of the tPA bands
9
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in our western blots as well as why actin
did not show up as it was expected to.
Studies concerning the localization
and abundance of tPA, plasmin and PAI-1
in the brain are scarce. The few studies
that do investigate their presence in the
brain are limited to the hippocampus,
cerebral cortex and hypothalamus. An
abundant and localized expression of tPA
is observed in the bed nucleus of the stria
terminalis (BST) in the hypothalamus;
restraint stress and injection of
corticotopin-releasing factor cause tPA to
be released into the extracellular space,
promoting neuronal activation [56]. The
function of this release however is not
known.
Of particular interest in my studies
is the reported interaction of tPA with the
NMDA (N-methyl D-aspartate) receptor.
tPA has been determined to act directly
with the NMDA receptor via subunit
cleavage [57] as well as indirectly via its
effects on BDNF. It has been determined
that when cortical neurons are
depolarized, they release tPA that
interacts with and cleaves the NR1
subunit of the NMDA receptor [57]. Thus,
tPA potentiates signaling mediated by
glutamatergic receptors by modifying the
properties of the NMDA receptor [57].
The cleavage interaction between the
subunit and tPA can be prevented by
addition of PAI-1 [57]. In addition, tPA
treatment selectively potentiates the
NMDA-induced increase in intracellular
Ca+2 concentrations, which is pertinent to
the activation of the NMDA receptor [57].
In the hippocampus, NMDA
receptors play a crucial role in long term
potentiation (LTP), which is the
mechanism for the production of long
term memory. tPA has profound effects
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on the late phase of LTP (L-LTP). An
inhibitor of tPA blocks L-LTP, whereas
extracellular application of tPA enhances
L-LTP induced by a single tetatus, which
by itself induces early LTP (E-LTP) [58].
Induction of L-LTP in turn enhances the
expression of tPA in the hippocampus
[59]. tPA can also be secreted from
neuronal growth cones and axonal
terminals [60], and neuronal membrane
depolarization also induces secretion of
tPA into the extracellular space in the
hippocampus in a Ca+2 dependent manner
[61]. The inactive zymogen, plasminogen
(which is converted to plasmin via tPA)
mRNA and protein in the hippocampus
are exclusively expressed in neurons and
primarily in the apical dendrites of
pyramidal cells [62]. Not only do tPA
knockout mice exhibit severe impairment
of L-LTP, so did plasmin knockout mice
[12]. Since it has been determined that a
major function of the tPA/plasmin system
is to convert proBDNF to mBDNF at
hippocampal synapses, it has also been
determined that such conversion is
critical and necessary for the expression
of L-LTP [12]. As already discussed, we
have determined the glutamate-induced
phase shifts require this conversion in the
SCN as well.

5.0 Conclusion
We
hypothesized
that
the
extracellular actions of tPA/plasmin
regulate mBDNF production which
modulates how glutamate signaling
affects SCN rhythmic activity. This led us
to
believe
that
the
expression,
localization, and activity levels of these
proteins are regulated in the SCN. Our
results suggest that tPA is expressed in
SCN neurons and present in the media.
However, we have yet to determine the
10
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pattern of tPA/plasmin and PAI-1
expression in the media due to difficulties
in normalizing actin to the protein
expression levels and the possibility of
non-specific binding of the tPA antibody
to other proteins. Future studies will
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initially focus on fine-tuning the actin
immunoblots and then will turn to
producing consistent protein expression
patterns.
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